These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 26164382)

  • 41. Preoperative plasma fibrinogen is associated with poor prognosis in esophageal carcinoma: a meta-analysis.
    Lv GY; Yu Y; An L; Sun XD; Sun DW
    Clin Transl Oncol; 2018 Jul; 20(7):853-861. PubMed ID: 29134563
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The Association Between Body Mass Index and the Prognosis and Postoperative Complications of Hepatocellular Carcinoma: A Meta-Analysis.
    Rong X; Wei F; Geng Q; Ruan J; Shen H; Li A; Luo R
    Medicine (Baltimore); 2015 Aug; 94(31):e1269. PubMed ID: 26252292
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Prognostic and clinicopathological value of Beclin-1 expression in hepatocellular carcinoma: a meta-analysis.
    Qin Z; Yu X; Lin M; Wu J; Ma S; Wang N
    World J Surg Oncol; 2018 Aug; 16(1):170. PubMed ID: 30107804
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Association between platelet to lymphocyte ratio (PLR) and overall survival (OS) of hepatocellular carcinoma (HCC): A meta-analysis.
    Hu DH; Yu SM
    Cell Mol Biol (Noisy-le-grand); 2017 Aug; 63(8):30-32. PubMed ID: 28886327
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Clinicopathologic and prognostic significance of tumor-associated macrophages in patients with hepatocellular carcinoma: A meta-analysis.
    Ding W; Tan Y; Qian Y; Xue W; Wang Y; Jiang P; Xu X
    PLoS One; 2019; 14(10):e0223971. PubMed ID: 31618252
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A meta-analysis of the prognostic impact of tissue golgi protein 73 (tGP73) in hepatocellular carcinoma.
    Yu WM; Li GW; Lou MG; Wu ZY
    BMC Gastroenterol; 2023 Nov; 23(1):401. PubMed ID: 37978447
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Tumor-stroma ratio is a prognostic factor for survival in hepatocellular carcinoma patients after liver resection or transplantation.
    Lv Z; Cai X; Weng X; Xiao H; Du C; Cheng J; Zhou L; Xie H; Sun K; Wu J; Zheng S
    Surgery; 2015 Jul; 158(1):142-50. PubMed ID: 25890776
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Molecular prediction of early recurrence after resection of hepatocellular carcinoma.
    Yoshioka S; Takemasa I; Nagano H; Kittaka N; Noda T; Wada H; Kobayashi S; Marubashi S; Takeda Y; Umeshita K; Dono K; Matsubara K; Monden M
    Eur J Cancer; 2009 Mar; 45(5):881-9. PubMed ID: 19167881
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The impact of chemokine receptor CXCR4 on breast cancer prognosis: a meta-analysis.
    Xu TP; Shen H; Liu LX; Shu YQ
    Cancer Epidemiol; 2013 Oct; 37(5):725-31. PubMed ID: 23763828
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Prognostic and clinicopathologic significance of SIRT1 expression in hepatocellular carcinoma.
    Jiang H; Zhang X; Tao Y; Shan L; Jiang Q; Yu Y; Cai F; Ma L
    Oncotarget; 2017 Aug; 8(32):52357-52365. PubMed ID: 28881735
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Bone marrow micrometastasis is associated with both disease recurrence and poor survival in surgical patients with node-negative non-small-cell lung cancer: a meta-analysis.
    Deng XF; Liu QX; Zhou D; Min JX; Dai JG
    Interact Cardiovasc Thorac Surg; 2015 Jul; 21(1):21-7. PubMed ID: 25883247
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Sarcopenia Predicts Prognosis of Patients Undergoing Liver Resection for Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis.
    Zhang H; Zhang L; Wang Y; Zou J; Zhang T
    Nutr Cancer; 2023; 75(3):776-784. PubMed ID: 36537813
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Different prognostic value of cytokeratin-19 mRNA positive circulating tumor cells according to estrogen receptor and HER2 status in early-stage breast cancer.
    Ignatiadis M; Xenidis N; Perraki M; Apostolaki S; Politaki E; Kafousi M; Stathopoulos EN; Stathopoulou A; Lianidou E; Chlouverakis G; Sotiriou C; Georgoulias V; Mavroudis D
    J Clin Oncol; 2007 Nov; 25(33):5194-202. PubMed ID: 17954712
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Adipose distribution patterns as prognostic factors in patients with HCC: A systematic review and meta-analysis.
    Shi S; Yi H; Zheng Y; Zhao Y; Yu D
    Eur J Radiol; 2023 Oct; 167():111025. PubMed ID: 37634440
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Proteomic profiling reveals the prognostic value of adenomatous polyposis coli-end-binding protein 1 in hepatocellular carcinoma.
    Orimo T; Ojima H; Hiraoka N; Saito S; Kosuge T; Kakisaka T; Yokoo H; Nakanishi K; Kamiyama T; Todo S; Hirohashi S; Kondo T
    Hepatology; 2008 Dec; 48(6):1851-63. PubMed ID: 18937283
    [TBL] [Abstract][Full Text] [Related]  

  • 56. High preoparative levels of serum periostin are associated with poor prognosis in patients with hepatocellular carcinoma after hepatectomy.
    Lv Y; Wang W; Jia WD; Sun QK; Huang M; Zhou HC; Xia HH; Liu WB; Chen H; Sun SN; Xu GL
    Eur J Surg Oncol; 2013 Oct; 39(10):1129-35. PubMed ID: 23916473
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Interleukin-12B+1188A/C polymorphism contributes to increased hepatocellular carcinoma susceptibility: evidence from a meta-analysis.
    Peng Q; Li S; Lao X; Chen Z; Li R; Qin X
    Clin Res Hepatol Gastroenterol; 2014 Dec; 38(6):735-43. PubMed ID: 25445750
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Loss of heterozygosity at D8S298 is a predictor for long-term survival of patients with tumor-node-metastasis stage I of hepatocellular carcinoma.
    Pang JZ; Qin LX; Ren N; Hei ZY; Ye QH; Jia WD; Sun BS; Lin GL; Liu DY; Liu YK; Tang ZY
    Clin Cancer Res; 2007 Dec; 13(24):7363-9. PubMed ID: 18094418
    [TBL] [Abstract][Full Text] [Related]  

  • 59. HULC and H19 Played Different Roles in Overall and Disease-Free Survival from Hepatocellular Carcinoma after Curative Hepatectomy: A Preliminary Analysis from Gene Expression Omnibus.
    Yang Z; Lu Y; Xu Q; Tang B; Park CK; Chen X
    Dis Markers; 2015; 2015():191029. PubMed ID: 26136615
    [TBL] [Abstract][Full Text] [Related]  

  • 60. CpG island methylator phenotype associated with tumor recurrence in tumor-node-metastasis stage I hepatocellular carcinoma.
    Li B; Liu W; Wang L; Li M; Wang J; Huang L; Huang P; Yuan Y
    Ann Surg Oncol; 2010 Jul; 17(7):1917-26. PubMed ID: 20112070
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.